Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.
Pharmacoepidemiol Drug Saf. 2011 Apr;20(4):432-9. doi: 10.1002/pds.2096. Epub 2011 Feb 3.
Patient antiretroviral (ARV) therapy knowledge is essential for regimen adherence, successful therapeutic response, and minimization of resistance evolution. Moreover, a complete and accurate patient ARV history is needed to construct efficacious and tolerable future regimens. In this study we assessed the ability of HIV-infected patients receiving care in a university infectious diseases clinic to accurately recall current and past ARVs.
A convenience sample (n = 205) of UNC HIV Clinical Cohort participants (n = 1840) completed a comprehensive in-person interview. Patients were asked about current and ever ARV use and were provided proprietary and generic ARV names and photographs. Self-reported sensitivity for current and ever ARV use (proportion that correctly identified all recorded ARVs), was calculated using the medical record as the gold standard.
One hundred and eighty-five patients had received ARVs at some point after enrollment in the cohort study (ever users). For current ARV use (n = 138), self-reported sensitivity was 63% (95% CI: 54-71). For ever use (n = 185), sensitivity was 18% (95% CI: 13-24).
Self-reported cumulative ARV use is not accurate. Since HIV-infected patients are prescribed a number of medications over their treatment course, it is necessary to develop new medication reconciliation techniques that are not dependent on patient memory or knowledge in order to improve patient outcomes.
患者抗逆转录病毒(ARV)治疗知识对于方案依从性、治疗成功和耐药性进化最小化至关重要。此外,需要完整、准确的患者 ARV 病史来构建有效的、可耐受的未来方案。在这项研究中,我们评估了在大学传染病诊所接受治疗的 HIV 感染患者准确回忆当前和既往 ARV 的能力。
UNC HIV 临床队列研究的便利样本(n=205)(n=1840)完成了全面的面对面访谈。患者被问及当前和既往的 ARV 使用情况,并提供了专有和通用的 ARV 名称和照片。使用病历作为金标准,根据自我报告的当前和既往 ARV 使用情况(正确识别所有记录的 ARV 的比例)计算敏感性。
185 名患者在队列研究入组后曾接受过 ARV 治疗(既往使用者)。对于当前 ARV 使用(n=138),自我报告的敏感性为 63%(95%CI:54-71)。对于既往使用(n=185),敏感性为 18%(95%CI:13-24)。
自我报告的累积 ARV 使用情况不准确。由于 HIV 感染患者在治疗过程中会服用多种药物,因此有必要开发新的药物一致性核对技术,这些技术不依赖于患者的记忆或知识,以改善患者的预后。